Securities laws restrict the offering of securities to
non-accredited investors. When a company is acquired for stock, non-accredited
employees, advisors and others may be required to have a Purchaser
Representative available to advise them. Similarly, certain transactions (e.g.,
transactions involving ESOP companies) require independent trustees.
We provide Purchaser Representative and Trustee Services that allow
transactions to proceed quickly and efficiently, while protecting the interests
of those we represent.
Transactions successfully completed:
Purchaser Representative for non-accredited
investors; acquisition of Q–RNA, Inc. by Neuro Hitech, Inc.
Purchaser Representative for non-accredited investors; acquisition
of Strategic Pricing Group, Inc. by The Monitor Group
Purchaser Representative for non-accredited investors; exchange of
capital stock of Cellzome AG for shares of a
Purchaser Representative for non-accredited investors; merger of NeuroVir Therapeutics, Inc. and MediGene
AG
Independent Trustee
of the John Solomon, Inc. Employee Stock Ownership Plan, in connection with the
purchase of substantially all of the assets of John Solomon, Inc. by QST
Industries, Inc.
Purchaser Representative for non-accredited investors; merger of
New Oak Communications, Inc. and Bay Networks, Inc.
Purchaser Representative for non-accredited investors; merger of Chemgenics Pharmaceuticals, Inc. and Millenium
Pharmaceuticals, Inc.
Purchaser Representative for non-accredited investors; merger of
Coelacanth Corporation and Lexicon Genetics Inc.
Purchaser Representative for non-accredited investors; merger of Mitotix, Inc. and a wholly-owned subsidiary of GPC Biotech
AG.
Purchaser Representative for non-accredited investors; combination
of Medical Foods, Inc. and AmeriFIT, Inc. into Amerifit Nutrition, Inc.